163 related articles for article (PubMed ID: 20711705)
21. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
22. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
Aslam M; Perkins SJ
J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional characterization of the product of disease-related factor H gene conversion.
Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
[TBL] [Abstract][Full Text] [Related]
24. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease.
Nan R; Gor J; Perkins SJ
J Mol Biol; 2008 Jan; 375(4):891-900. PubMed ID: 18054958
[TBL] [Abstract][Full Text] [Related]
25. Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy.
Perkins SJ; Okemefuna AI; Nan R
Biochem Soc Trans; 2010 Aug; 38(4):894-900. PubMed ID: 20658973
[TBL] [Abstract][Full Text] [Related]
26. The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells.
Sjöberg AP; Trouw LA; Clark SJ; Sjölander J; Heinegård D; Sim RB; Day AJ; Blom AM
J Biol Chem; 2007 Apr; 282(15):10894-900. PubMed ID: 17293598
[TBL] [Abstract][Full Text] [Related]
27. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.
Duthy TG; Ormsby RJ; Giannakis E; Ogunniyi AD; Stroeher UH; Paton JC; Gordon DL
Infect Immun; 2002 Oct; 70(10):5604-11. PubMed ID: 12228288
[TBL] [Abstract][Full Text] [Related]
28. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
29. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
Laine M; Jarva H; Seitsonen S; Haapasalo K; Lehtinen MJ; Lindeman N; Anderson DH; Johnson PT; Järvelä I; Jokiranta TS; Hageman GS; Immonen I; Meri S
J Immunol; 2007 Mar; 178(6):3831-6. PubMed ID: 17339482
[TBL] [Abstract][Full Text] [Related]
30. Zinc-induced self-association of complement C3b and Factor H: implications for inflammation and age-related macular degeneration.
Nan R; Tetchner S; Rodriguez E; Pao PJ; Gor J; Lengyel I; Perkins SJ
J Biol Chem; 2013 Jun; 288(26):19197-210. PubMed ID: 23661701
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
Front Immunol; 2020; 11():1728. PubMed ID: 32849614
[TBL] [Abstract][Full Text] [Related]
32. Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade.
Makou E; Bailey RG; Johnston H; Parkin JD; Hulme AN; Hähner G; Barlow PN
J Biol Chem; 2019 Dec; 294(52):20148-20163. PubMed ID: 31719147
[TBL] [Abstract][Full Text] [Related]
33. Bivalent and co-operative binding of complement factor H to heparan sulfate and heparin.
Khan S; Nan R; Gor J; Mulloy B; Perkins SJ
Biochem J; 2012 Jun; 444(3):417-28. PubMed ID: 22471560
[TBL] [Abstract][Full Text] [Related]
34. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
[TBL] [Abstract][Full Text] [Related]
35. Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease.
Nan R; Gor J; Lengyel I; Perkins SJ
J Mol Biol; 2008 Dec; 384(5):1341-52. PubMed ID: 18976665
[TBL] [Abstract][Full Text] [Related]
36. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
[TBL] [Abstract][Full Text] [Related]
37. Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
Li K; Gor J; Holers VM; Storek MJ; Perkins SJ
J Mol Biol; 2012 May; 418(3-4):248-63. PubMed ID: 22387467
[TBL] [Abstract][Full Text] [Related]
38. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
[TBL] [Abstract][Full Text] [Related]
39. Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex.
E S Harrison R; Gorham RD; Morikis D
Protein Sci; 2015 May; 24(5):789-802. PubMed ID: 25628052
[TBL] [Abstract][Full Text] [Related]
40. Electrostatic interactions contribute to the folded-back conformation of wild type human factor H.
Okemefuna AI; Nan R; Gor J; Perkins SJ
J Mol Biol; 2009 Aug; 391(1):98-118. PubMed ID: 19505476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
